Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Hemangioblastoma; Von Hippel-Lindau Disease | Phase 2 | ClinicalTrials |
| Breast Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms | Phase 1 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 2 | ClinicalTrials |
| Neoplasm Metastasis | Phase 1/Phase 2 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, Large B-Cell, Diffuse | Phase 2 | ClinicalTrials |
| Breast Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Gastrointestinal Stromal Tumors; Sarcoma | Phase 2 | ClinicalTrials |
| Melanoma | Phase 1/Phase 2 | ClinicalTrials |
| Prostatic Neoplasms | Phase 2 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Lung Neoplasms; Mesothelioma | Phase 2 | ClinicalTrials |
| Adenocarcinoma | Phase 2 | ClinicalTrials |
| Choroidal Neovascularization; Macular Degeneration; Neovascularization, Pathologic | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms | Phase 2 | ClinicalTrials |
| Glioblastoma | Phase 1 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 2 | ClinicalTrials |
CONTENTS